Cefdinir and Brimonidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Brimonidine (brimonidine). Common drug interactions include malignant neoplasm progression among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Brimonidine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Brimonidine?

Brimonidine has active ingredients of brimonidine. It is often used in glaucoma. eHealthMe is studying from 6,276 Brimonidine users. Check the latest studies of Brimonidine.

On Jul, 07, 2026

12 people who take Cefdinir and Brimonidine together, and have interactions are studied.

Cefdinir and Brimonidine drug interactions.

What are the common drug interactions of Cefdinir and Brimonidine, by gender? *:

female:

Malignant neoplasm progression (cancer tumour came back)
Nephrogenic anaemia (anaemia due to kidney disease)
Pneumonia
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chronic kidney disease
Device failure
Neuralgia (pain in one or more nerves)
Renal failure (kidney dysfunction)
Drug ineffective

male:

Death
Ejection fraction decreased (systolic heart failure)
Febrile neutropenia (fever with reduced white blood cells)
Pneumonia

What are the common drug interactions of Cefdinir and Brimonidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

Pneumonia
Drug ineffective
Ejection fraction decreased (systolic heart failure)
Febrile neutropenia (fever with reduced white blood cells)
Malignant neoplasm progression (cancer tumour came back)
Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 6 people, 50.00%
High Blood Pressure: 5 people, 41.67%
Eye Irritation: 4 people, 33.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 25.00%
Diabetes: 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
High Blood Cholesterol: 3 people, 25.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 25.00%
Nausea And Vomiting: 2 people, 16.67%
Rashes (redness): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Brimonidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously